Junqing Xie

TL;DR: Hydxychloroquine treatment appears to have no increased risk in the short term among patients with rheumatoid arthritis, but in the long term it appears to be associated with excess cardiovascular mortality.

TL;DR: In this article, the authors compared the associations of tramadol compared with codeine, with mortality and other adverse clinical outcomes as used in outpatient settings, and found that tramadols were significantly associated with a higher risk of all-cause mortality, cardiovascular events, fractures, constipation, delirium, falls, opioid abuse/dependence, and sleep disorders within 1 year after the first dispensation.

TL;DR: HCQ as used to treat RA does not appear to increase the risk of depression, suicide/suicidal ideation or psychosis compared with SSZ, and use at a higher dose or for different indications needs further investigation.

TL;DR: In this article, a prospective study with participants from the UK Biobank cohort was conducted to examine association between smoking and COVID-19 infection and subsequent mortality, and the authors found that older smokers were twice more likely to die from COVID19 than never smokers, possibly mediated by increased risk of chronic conditions or illnesses.

TL;DR: Hydxychloroquine as used to treat RA does not appear to increase the risk of depression, suicide/suicidal ideation, or psychosis compared to sulfasalazine, and use at higher dose or for different indications needs further investigation.